Ann M. Arvin

Active 1976–2025

114
Papers
21,298
Citations
90
h-index
114
i10-index

Citations

Citations per year for Ann M. Arvin1978: 10 citations1979: 9 citations1980: 16 citations1981: 7 citations1982: 29 citations1983: 25 citations1984: 17 citations1985: 16 citations1986: 24 citations1987: 20 citations1988: 30 citations1989: 31 citations1990: 20 citations1991: 48 citations1992: 65 citations1993: 32 citations1994: 33 citations1995: 28 citations1996: 89 citations1997: 55 citations1998: 64 citations1999: 53 citations2000: 80 citations2001: 117 citations2002: 116 citations2003: 88 citations2004: 106 citations2005: 160 citations2006: 98 citations2007: 107 citations2008: 150 citations2009: 103 citations2010: 154 citations2011: 139 citations2012: 111 citations2013: 120 citations2014: 130 citations2015: 97 citations2016: 76 citations2017: 68 citations2018: 103 citations2019: 340 citations2020: 377 citations2021: 466 citations2022: 315 citations2023: 139 citations2024: 262 citations2025: 94 citations2026: 2 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,743 citing papers, 35.1% of this breakdownUnited Kingdom: 379 citing papers, 7.6% of this breakdownChina: 283 citing papers, 5.7% of this breakdownGermany: 253 citing papers, 5.1% of this breakdownCanada: 179 citing papers, 3.6% of this breakdownItaly: 157 citing papers, 3.2% of this breakdownAustralia: 154 citing papers, 3.1% of this breakdownFrance: 147 citing papers, 3% of this breakdownBelgium: 104 citing papers, 2.1% of this breakdownSwitzerland: 103 citing papers, 2.1% of this breakdownNetherlands: 102 citing papers, 2% of this breakdownJapan: 94 citing papers, 1.9% of this breakdown
0%35.1%Other 25.5%

Fields

  • Medicine79.3%
  • Immunology and Microbiology8.2%
  • Biochemistry, Genetics and Molecular Biology7.5%
  • Social Sciences0.7%
  • Mathematics0.6%
  • Neuroscience0.6%
  • Other3.1%

Topics

  • Herpesvirus Infections and Treatments13.7%
  • Cytomegalovirus and herpesvirus research9.3%
  • SARS-CoV-2 and COVID-19 Research5.1%
  • Influenza Virus Research Studies2.8%
  • Immune Cell Function and Interaction2.6%
  • COVID-19 Clinical Research Studies2.3%
  • Other64.2%

Coauthors

All papers

Open in search
  1. After the pandemic: perspectives on the future trajectory of COVID-19

    Authors: , , , , , , , , , - Nature 2021 cited by 445

  2. Molecular mechanisms of varicella zoster virus pathogenesis

    Authors: , , , - Nature Reviews Microbiology 2014 cited by 476

  3. A perspective on potential antibody-dependent enhancement of SARS-CoV-2

    Authors: , , , , , , , , - Nature 2020 cited by 537

  4. Varicella-zoster virus

    Authors: - Clinical Microbiology Reviews 1996 cited by 1,159

  5. Cellular Immune Responses in Children and Adults Receiving Inactivated or Live Attenuated Influenza Vaccines

    Authors: , , , , , , , , - Journal of Virology 2006 cited by 322

  6. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis

    Authors: , , , , , , - 2007 cited by 873

  7. Chemotherapy-induced immunosuppression.

    Authors: , - Environmental Health Perspectives 1982 cited by 110

  8. Prospects for a safe COVID-19 vaccine

    Authors: , , , , , , , , , - Science Translational Medicine 2020 cited by 275

  9. Tropism of Varicella-Zoster Virus for Human Tonsillar CD4+T Lymphocytes That Express Activation, Memory, and Skin Homing Markers

    Authors: , , , , - Journal of Virology 2002 cited by 148

  10. Targeted mutagenesis of the herpesvirus fusogen central helix captures transition states

    Authors: , , , , , , , - Nature Communications 2023 cited by 15

  11. Aging, Immunity, and the Varicella–Zoster Virus

    Authors: - New England Journal of Medicine 2005 cited by 306

  12. Persistent and Selective Deficiency of CD4+ T Cell Immunity to Cytomegalovirus in Immunocompetent Young Children

    Authors: , , , , , , , , , , , , - The Journal of Immunology 2004 cited by 201

  13. Varicella-Zoster Virus Infections in Patients Treated With Fingolimod

    Authors: , , , , , , , , , , - JAMA Neurology 2014 cited by 178

  14. Mechanisms of Varicella-Zoster Virus Neuropathogenesis in Human Dorsal Root Ganglia

    Authors: , , - Journal of Virology 2008 cited by 133

  15. Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Geoffrey Playford, Joe Sasadeusz, Johan Maertens, Xavier Poiré, D Sellesag, R Schots, Koen Theunissen, E. Willems, RS Alves, JFC Camargo, NS Castro, Laura Maria Fogliatto, O Rodrigo, F Courture, Allison McGeer, Marissa A. Miller, Juan Felipe Combariza, CL Sossa, JD Velez, Dan Nemet, Slobodanka Ostojić Kolonić, Ladislav Jebavý, John M. Mayer, Jan Novák, David Pohlreich, Beatriz García Maldonado, Thomas Gastinne, Lionel Karlin, Odile Launay, Oliver A. Cornely, H. Duerk, Mathias Haenel, Werner Heinz, Martin Kaufmann, Jens Panse, Daniel Teschner, M. Verbeek, Gerald Wulf, Freddy Aviv, Sigal Grisariu, Arnon Nagler, Moshe Yeshurun, Alberto Bosi, Paolo Corradini, G Martinelli, Francesco Onida, Alessandro Rambaldi, Andrea Velardi, Igoris Trociukas, AD Gomez, MJ Wondergem, PF Ypma, Ernesto Fanilla, MDC Moreno Larrea, MM Abecasis, Ricardo B. Ferreira, Catarina Geraldes, João Jácome de Castro, B. Afanasyev, I. V. Kruchkova, AY Zaritskiy, JW Cheong, Sung‐Jae Kim, DG Lee, SS Yoon, Blanca Bueno, Irene Ramos, Carlos Solano Vercet, Honar Cherif, Per Ljungman and 60 more - The Lancet 2018 cited by 96

  16. T-Cell Tropism and the Role of ORF66 Protein in Pathogenesis of Varicella-Zoster Virus Infection

    Authors: , , , , , , , - Journal of Virology 2005 cited by 82

  17. A glycoprotein B-neutralizing antibody structure at 2.8 Å uncovers a critical domain for herpesvirus fusion initiation

    Authors: , , , , , , , , , , - Nature Communications 2020 cited by 44

  18. Safety and Efficacy of High-Dose Intravenous Acyclovir in the Management of Neonatal Herpes Simplex Virus Infections

    Authors: , , , , , , , , , , , , , , , , , , , , - PEDIATRICS 2001 cited by 575

  19. Natural History of Neonatal Herpes Simplex Virus Infections in the Acyclovir Era

    Authors: , , , , , , , , , , , , , , , , , , , - PEDIATRICS 2001 cited by 511

  20. Varicella-Zoster Virus Transfer to Skin by T Cells and Modulation of Viral Replication by Epidermal Cell Interferon-α

    Authors: , , , , , - The Journal of Experimental Medicine 2004 cited by 227

  21. T cell–dependent production of IFN-γ by NK cells in response to influenza A virus

    Authors: , , , , , , , , - Journal of Clinical Investigation 2004 cited by 155

  22. Modulation of Major Histocompatibility Class II Protein Expression by Varicella-Zoster Virus

    Authors: , , , , , - Journal of Virology 2000 cited by 136

  23. Varicella-Zoster Virus Infection Triggers Formation of an Interleukin-1β (IL-1β)-processing Inflammasome Complex

    Authors: , , , , , - Journal of Biological Chemistry 2011 cited by 99

  24. Current In Vivo Models of Varicella-Zoster Virus Neurotropism

    Authors: , , , , , , , , , - Viruses 2019 cited by 51